BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28543730)

  • 1. Treatment of disseminated superficial actinic porokeratosis with oral alitretinoin.
    Park BJ; Oh EH; Kim JE; Ko JY; Ro YS
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):e505-e507. PubMed ID: 28543730
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of disseminated superficial actinic porokeratosis with calcipotriol.
    Bakardzhiev I; Kavaklieva S; Pehlivanov G
    Int J Dermatol; 2012 Sep; 51(9):1139-42. PubMed ID: 21726212
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated superficial actinic porokeratosis treated with ingenol mebutate gel 0.05.
    Anderson I; Routt ET; Jim On SC
    Cutis; 2017 Mar; 99(3):E36-E39. PubMed ID: 28398427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated superficial actinic porokeratosis of the scalp.
    Naineni KK; Hohle R; Lucke T
    Clin Exp Dermatol; 2007 Mar; 32(2):222-3. PubMed ID: 17137476
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated superficial actinic porokeratosis responding to calcipotriol.
    Harrison PV; Stollery N
    Clin Exp Dermatol; 1994 Jan; 19(1):95. PubMed ID: 8313653
    [No Abstract]   [Full Text] [Related]  

  • 6. Type 2 segmental manifestation of disseminated superficial actinic porokeratosis in a 7-year-old girl.
    Niimi Y; Kawana S
    Eur J Dermatol; 2009; 19(1):25-8. PubMed ID: 19059828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split-face trial of CO(2) laser-induced ring abrasion and high-dose tacalcitol in the treatment of disseminated superficial actinic porokeratosis.
    Noborio R; Morita A
    J Dermatol; 2012 Oct; 39(10):879-80. PubMed ID: 22220840
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful management of disseminated superficial actinic porokeratosis with diclofenac sodium 3% gel.
    Otero-Rivas MM; Rodríguez-Lojo R; Castiñeiras-Mato IM; Lueiro-Vilariño M; Juárez-Casado Y; Fernández-Díaz ML
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 27859984
    [No Abstract]   [Full Text] [Related]  

  • 9. Facial porokeratosis: A series of six patients.
    Gutierrez EL; Galarza C; Ramos W; Tello M; De Paz PC; Bobbio L; Barquinero A; Ronceros G; Ortega-Loayza AG
    Australas J Dermatol; 2010 Aug; 51(3):191-4. PubMed ID: 20695858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of porokeratosis of Mibelli with ingenol mebutate: a possible new therapeutic option.
    Kindem S; Serra-Guillén C; Sorní G; Guillén C; Sanmartín O
    JAMA Dermatol; 2015 Jan; 151(1):85-6. PubMed ID: 25409424
    [No Abstract]   [Full Text] [Related]  

  • 11. Coexistence of linear porokeratosis and disseminated superficial actinic porokeratosis: a type 2 segmental manifestation.
    Suárez-Amor O; Pereiro-Ferreirós M; Ginarte M; Peteiro C; Toribio J
    Acta Derm Venereol; 2007; 87(4):363-4. PubMed ID: 17598043
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcipotriol and adapalene therapy for disseminated superficial actinic porokeratosis.
    Nakamura Y; Yamaguchi M; Nakamura A; Muto M
    Indian J Dermatol Venereol Leprol; 2014; 80(4):373-4. PubMed ID: 25035379
    [No Abstract]   [Full Text] [Related]  

  • 13. Disseminated superficial actinic porokeratosis: treatment with topical tacalcitol.
    Böhm M; Luger TA; Bonsmann G
    J Am Acad Dermatol; 1999 Mar; 40(3):479-80. PubMed ID: 10071323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Update on the Use of Alitretinoin for Chronic Hand Dermatitis in a Dermatology Practice Setting.
    Crowley EL; Sayeau RL; Gooderham MJ
    J Cutan Med Surg; 2018; 22(1):102-103. PubMed ID: 29309241
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinate-photodynamic therapy.
    Cavicchini S; Tourlaki A
    J Dermatolog Treat; 2006; 17(3):190-1. PubMed ID: 16854765
    [No Abstract]   [Full Text] [Related]  

  • 16. Alitretinoin can be a good treatment option for idiopathic recalcitrant trachyonychia in adults: an open-label study.
    Shin K; Kim TW; Park SM; Lee HJ; Jin H; You HS; Shim WH; Kim GW; Kim HS; Ko HC; Kim BS; Kim MB
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1810-1814. PubMed ID: 29704273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alitretinoin for prurigo nodularis.
    Maqbool T; Kraft JN
    Clin Exp Dermatol; 2021 Mar; 46(2):362-363. PubMed ID: 33464627
    [No Abstract]   [Full Text] [Related]  

  • 18. A rare cause of annular papules. Disseminated superficial actinic porokeratosis.
    Roark TR; Hsu S
    Postgrad Med; 2000 Nov; 108(6):153-4. PubMed ID: 11098266
    [No Abstract]   [Full Text] [Related]  

  • 19. Porokeratosis Ptychotropica.
    Liu W; Liu JW; Ma DL
    JAMA Dermatol; 2019 Jul; 155(7):845. PubMed ID: 31090870
    [No Abstract]   [Full Text] [Related]  

  • 20. The hyperkeratotic variant of porokeratosis Mibelli is a distinct entity: clinical and ultrastructural evidence.
    Schaller M; Korting HC; Kollmann M; Kind P
    Dermatology; 1996; 192(3):255-8. PubMed ID: 8726642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.